New study aims to predict who will respond to chemoradiation for head and neck cancer

NCT ID NCT07259915

Not yet recruiting Knowledge-focused Sponsor: Centre Henri Becquerel Source: ClinicalTrials.gov ↗

First seen Jan 10, 2026 · Last updated May 17, 2026 · Updated 15 times

Summary

This study will test whether combining imaging scans (CT, MRI, PET) with tumor DNA detection can better predict how head and neck cancer responds to chemoradiotherapy. Researchers will enroll 152 people with advanced oropharyngeal or oral cavity cancer. The goal is to improve personalized treatment decisions, not to test a new therapy.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SQUAMOUS CELL CANCER OF HEAD AND NECK (SCCHN) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Centre Henri Becquerel

Rouen, France

Contact Phone: •••-•••-•••• Email: •••••@•••••
Centre Hospitalier Universitaire

Rouen, France

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

SQUAMOUS CELL CANCER OF HEAD AND NECK (SCCHN)